1 Choe J, "mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis" 561 : 556-560, 2018
2 Di Gioia D, "Tumor markers in the early detection of tumor recurrence in breast cancer patients : CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3" 461 : 1-7, 2016
3 Nam SE, "The prognostic significance of preoperative tumor marker(CEA, CA15-3)elevation in breast cancer patients : data from the Korean Breast Cancer Society Registry" 177 : 669-678, 2019
4 Lan Q, "The critical role of RNA m(6)A methylation in cancer" 79 : 1285-1292, 2019
5 Edge SB, "The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM" 17 : 1471-1474, 2010
6 Deng X, "Role of N(6)-methyladenosine modification in cancer" 48 : 1-7, 2018
7 Deng X, "RNA N(6)-methyladenosine modification in cancers : current status and perspectives" 28 : 507-517, 2018
8 Halvorsen AR, "Profiling of microRNAs in tumor interstitial fluid of breast tumors : a novel resource to identify biomarkers for prognostic classification and detection of cancer" 11 : 220-234, 2017
9 Chen J, "Novel positioning from obesity to cancer : FTO, an m(6)A RNA demethylase, regulates tumour progression" 145 : 19-29, 2019
10 Liu L, "N6-methyladenosine-related genomic targets are altered in breast cancer tissue and associated with poor survival" 10 : 5447-5459, 2019
1 Choe J, "mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis" 561 : 556-560, 2018
2 Di Gioia D, "Tumor markers in the early detection of tumor recurrence in breast cancer patients : CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3" 461 : 1-7, 2016
3 Nam SE, "The prognostic significance of preoperative tumor marker(CEA, CA15-3)elevation in breast cancer patients : data from the Korean Breast Cancer Society Registry" 177 : 669-678, 2019
4 Lan Q, "The critical role of RNA m(6)A methylation in cancer" 79 : 1285-1292, 2019
5 Edge SB, "The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM" 17 : 1471-1474, 2010
6 Deng X, "Role of N(6)-methyladenosine modification in cancer" 48 : 1-7, 2018
7 Deng X, "RNA N(6)-methyladenosine modification in cancers : current status and perspectives" 28 : 507-517, 2018
8 Halvorsen AR, "Profiling of microRNAs in tumor interstitial fluid of breast tumors : a novel resource to identify biomarkers for prognostic classification and detection of cancer" 11 : 220-234, 2017
9 Chen J, "Novel positioning from obesity to cancer : FTO, an m(6)A RNA demethylase, regulates tumour progression" 145 : 19-29, 2019
10 Liu L, "N6-methyladenosine-related genomic targets are altered in breast cancer tissue and associated with poor survival" 10 : 5447-5459, 2019
11 Wang H, "N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1" 18 : 181-, 2019
12 Wang H, "N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2" 722 : 144076-, 2020
13 Hu BB, "N(6)-methyladenosine(m(6)A)RNA modification in gastrointestinal tract cancers : roles, mechanisms, and applications" 18 : 178-, 2019
14 Chavez-MacGregor M, "Incorporating tumor characteristics to the American Joint Committee on Cancer breast cancer staging system" 22 : 1292-1300, 2017
15 Zhang L, "IL1R2 blockade suppresses breast tumorigenesis and progression by impairing USP15-dependent BMI1 stability" 7 : 1901728-, 2020
16 Zhang C, "Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m(6)A-demethylation of NANOG mRNA" 113 : E2047-56, 2016
17 He L, "Functions of N6-methyladenosine and its role in cancer" 18 : 176-, 2019
18 Li Z, "FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase" 31 : 127-141, 2017
19 Becker A, "Extracellular vesicles in cancer : cell-to-cell mediators of metastasis" 30 : 836-848, 2016
20 Pasculli B, "Epigenetics of breast cancer : Biology and clinical implication in the era of precision medicine" 51 : 22-35, 2018
21 Gao Y, "Diagnostic value of seven biomarkers for breast cancer : an overview with evidence mapping and indirect comparisons of diagnostic test accuracy" 20 : 97-108, 2020
22 Shen F, "Decreased N(6)-methyladenosine in peripheral blood RNA from diabetic patients is associated with FTO expression rather than ALKBH5" 100 : E148-54, 2015
23 Gkountela S, "Circulating tumor cell clustering shapes DNA methylation to enable metastasis Seeding" 176 : 98-112, 2019
24 Wu L, "Changes of N6-methyladenosine modulators promote breast cancer progression" 19 : 326-, 2019
25 Cheng J, "Cell-free circulating DNA integrity based on peripheral blood as a biomarker for diagnosis of cancer : a systematic review" 26 : 1595-1602, 2017
26 Tang Q, "Blood-based DNA methylation as biomarker for breast cancer : a systematic review" 8 : 115-, 2016
27 Bodelon C, "Blood DNA methylation and breast cancer risk : a meta-analysis of four prospective cohort studies" 21 : 62-, 2019
28 Koh CW, "Atlas of quantitative single-baseresolution N(6)-methyl-adenine methylomes" 10 : 5636-, 2019
29 Tang J, "A prognostic 10-lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients" 23 : 6775-6784, 2019